Proto Labs (PRLB) Liabilities and Shareholders Equity (2011 - 2026)

Proto Labs has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $791.3 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 6.46% year-over-year to $791.3 million; the TTM figure through Jun 2026 stood at $3.1 billion (up 3.77% YoY), while the FY2025 annual figure was $763.4 million, up 2.68% from the prior year.
• Liabilities and Shareholders Equity came in at $791.3 million for Q2 2026 at Proto Labs, up from $778.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $934.8 million in Q1 2022 to a low of $737.4 million in Q1 2025.
• Average Liabilities and Shareholders Equity over 5 years is $793.5 million, with a median of $774.8 million recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity dropped 15.4% in 2023 and grew 6.46% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $802.2 million in 2022, then retreated by 3.72% to $772.4 million in 2023, then decreased by 3.73% to $743.5 million in 2024, then climbed by 2.68% to $763.4 million in 2025, then advanced by 3.65% to $791.3 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $791.3 million in Q2 2026, $778.6 million in Q1 2026, and $763.4 million in Q4 2025.